General Information of the Compound
| Compound ID |
CP0422213
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-((S)-2-aminopropyl)-7-chloro-1H-indazol-6-ol
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-((S)-2-aminopropyl)-7-chloro-1H-indazol-6-ol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C10H12ClN3O
|
||||||||||||||||||
| Molecular Weight |
225.679
|
||||||||||||||||||
| Canonical SMILES |
C[C@H](N)Cn1ncc2ccc(O)c(Cl)c12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C10H12ClN3O/c1-6(12)5-14-10-7(4-13-14)2-3-8(15)9(10)11/h2-4,6,15H,5,12H2,1H3/t6-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VCXUEWRCJZWCJB-LURJTMIESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Protein ID: PT01480, 5-hydroxytryptamine receptor 2C
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Clinical Information about the Compound